BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
274 hedge funds and large institutions have $5.27B invested in bluebird bio in 2019 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 92 increasing their positions, 70 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
274
Holders Change
+33
Holders Change %
+13.69%
% of All Funds
5.41%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
69
Increased
92
Reduced
70
Closed
34
Calls
$103M
Puts
$71.3M
Net Calls
+$31.2M
Net Calls Change
+$52.9M
Top Buyers
1 |
![]()
Sands Capital Management
Arlington,
Virginia
|
+$87.4M |
2 |
Citadel Advisors
Miami,
Florida
|
+$50.5M |
3 |
TCM
TimesSquare Capital Management
New York
|
+$48.3M |
4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$42M |
5 |
Goldman Sachs
New York
|
+$31.5M |